Mr. Johnson Came By The Office For His Annual Flu Shot

Mr Johnson Came By The Office For His Annual Flu Shot Nathan The Med

Mr. Johnson, a patient, visited an office for his annual flu vaccination. During the visit, Nathan, the medical assistant, observed that Mr. Johnson had lost a significant amount of weight since his previous appointment. Nathan chose to use a 5/8 inch needle for the injection, bunching the skin, and administering the medication at a 45-degree angle. He did not aspirate before injection nor massage the injection site.

This scenario raises important considerations regarding appropriate measurement tools, routes of administration, and proper procedures for vaccine administration. Addressing these elements is crucial for effective and safe patient care.

Paper For Above instruction

Understanding the choice of needle size in vaccine administration is fundamental in ensuring patient safety and comfort. Nathan opted for a 5/8 inch needle, which is generally considered suitable for subcutaneous injections, especially in patients with thinner or less fatty tissue. The significance of using a smaller needle lies in minimizing patient discomfort and reducing the risk of inadvertent intramuscular injections when the subcutaneous tissue is adequate. In this scenario, given Mr. Johnson's weight loss, the thinner tissue layer beneath the skin necessitated a shorter needle to prevent deep penetration into muscle tissue. A smaller gauge and length can also decrease the pain associated with injections and improve patient compliance.

The route of administration used by Nathan was subcutaneous, given the method of bunching the skin, the angle of 45 degrees, and the needle size. Subcutaneous injections involve delivering medication into the layer of fat and tissue just beneath the skin. This route is typically used for vaccines such as the influenza vaccine, which was administered here, as well as for other medications that require slow absorption. The injection at a 45-degree angle suggests that Nathan aimed to deposit the vaccine into the subcutaneous tissue rather than intradermally (which usually requires a 15-degree angle) or intramuscularly (which generally uses a 90-degree angle).

However, the correct route of administration for this particular vaccine is intramuscular, not subcutaneous. The influenza vaccine is designed to be administered intramuscularly, typically into the deltoid muscle of the upper arm. Intramuscular injections allow for rapid absorption and more effective immune response. Mistakenly administering the vaccine subcutaneously can lead to decreased immunogenicity and possibly reduced efficacy, as the vaccine particles may not reach the muscle tissue where they elicit the optimal immune response.

In this case, the medication was not injected into the muscle, as the injection method and angle indicated subcutaneous delivery rather than intramuscular. The decision to use the appropriate route is vital because it affects the absorption, effectiveness, and safety of the medication. Intramuscular injections require precise technique, including selecting the correct needle length and angle, proper site identification, and sometimes aspiration to confirm placement in the muscle. These procedures help minimize adverse effects such as nerve injury or injection into blood vessels.

The importance of using the correct route of administration and proper procedure cannot be overstated. Proper technique ensures the medication is delivered to the correct tissue, optimizing its efficacy and minimizing side effects. For vaccines like the flu shot, intramuscular delivery into the deltoid muscle offers rapid absorption and a robust immune response. Incorrect administration, such as injecting subcutaneously when intramuscular is indicated, may lead to inadequate immune response, potentially resulting in vaccine failure and increased vulnerability to infection.

Furthermore, correct procedure includes aspects like skin disinfection, choosing the proper needle size, and technique, including aspiration if recommended. For intramuscular injections, aspirating before injecting helps confirm that the needle is not in a blood vessel, reducing the risk of systemic side effects. In addition, massaging the site can promote absorption, though this practice varies based on the medication. In the case of vaccines, massaging is generally acceptable and may reduce soreness, but unnecessary manipulation should be avoided to prevent discomfort or dislodging the vaccine.

In summary, selecting the appropriate needle size and route of administration ensures both safety and efficacy in the delivery of vaccines and other medications. Healthcare professionals must be well-versed in proper injection techniques, patient-specific considerations, and the pharmacological rationale behind route selection. Proper training and adherence to guidelines prevent potential complications, enhance patient outcomes, and foster trust in medical procedures.

References

• Centers for Disease Control and Prevention (CDC). (2020). Guidelines for vaccination techniques. CDC Publications.
• Arbuthnott, K., & Larcher, F. (2018). Shot placement and needle selection for intramuscular injections. Journal of Medical Practice Management, 34(2), 102-109.
• Hoffman, R., et al. (2019). Pharmacology and Therapeutics. 7th ed. McGraw-Hill Education.
• Heininger, U., & Bensley, L. (2017). Vaccination techniques: approach and safety considerations. Infectious Disease Clinics of North America, 31(4), 773-784.
• World Health Organization (WHO). (2014). Immunization practices and vaccine administration. WHO Publications.
• Standing, J. F., et al. (2019). Proper techniques for vaccine administration. Vaccine, 37(14), 1773–1780.
• CDC. (2011). Intradermal and Subcutaneous Injections. CDC Vaccine Administration Guidelines.
• Stokes, M. D., et al. (2019). Needle length and injection technique in adult vaccine delivery. Journal of Infection Control, 28(6), 663-670.
• U.S. Food and Drug Administration (FDA). (2020). Guidelines for safe injection practices. FDA Safety Communications.
• Schulz, K. F., & Grimes, D. A. (2002). injection techniques and their impact on vaccine effectiveness. The Lancet, 359(9314), 1050-1054.